Alan Fuhrman is on the board of Esperion Therapeutics, Inc., Washington Biotechnology & Biomedical Association, SpringWorks Therapeutics LLC and Springworks Therapeutics, Inc. In his past career Mr. Fuhrman was Independent Director at Checkmate Pharmaceuticals, Inc., President & Chief Operating Officer of Integrex, Inc., Chief Financial Officer & Senior Vice President at Sonus Pharmaceuticals, Inc., Chief Financial Officer of NeoPath, Inc., Chief Financial Officer & Vice President at Naviscan, Inc., Chief Financial Officer of Ambit Biosciences Corp., Chief Financial Officer at Capital Stream, Inc., Chief Financial Officer of Medisystems Corp., CFO & Principal Accounting Officer at Mirna Therapeutics, Inc. and Chief Financial Officer at Amplyx Pharmaceuticals, Inc.

Alan Fuhrman received an undergraduate degree from Montana State University.